Nasdaq GlobeNewswire

OmniComm Systems Signs Letter of Intent to Acquire Certain Assets of Algorithm and its Subsidiary Algorics

Del

Acquisition Will Expand OmniComm's Product Line With Data Analytics and Risk-Based Monitoring Solutions

FORT LAUDERDALE, Fla., Nov. 21, 2017 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTCQX:OMCM), a leading global provider of clinical data management technology, and  Algorithm, Inc. and its subsidiaries Algorics Ltd. and Algorithm Informatics Pvt. Ltd. (collectively, "Algorics"), have signed a letter of intent ("LOI"), under which OmniComm will acquire certain assets and assume certain liabilities of Algorics, a provider of clinical analytics solutions and software. By combining forces, the companies expect increased operating efficiency, strengthened traction in the maturing risk-based approach solution area, new marketing opportunities and an expanded portfolio of electronic data capture (EDC) solutions for the global clinical trials industry. The transaction would also provide OmniComm with an office in India, a country of growing importance in the clinical trials market.

The proposed acquisition will cement the existing collaboration between the companies and provide OmniComm with access to advanced data analytics capabilities and specialized algorithms, including artificial intelligence/machine learning, developed by Algorics.

"We've been partnering with OmniComm for the last two and a half years. The companies are a very good fit culturally, with a high compatibility of technologies and shared vision for clinical trials innovation," said Nithiya Ananthakrishnan, CEO and founder of Algorics. "Algorics has developed algorithms and software to address the increasing demands from global regulatory bodies for reduced regulatory risk, improved quality and compliance with real-time insight. Joining OmniComm will accelerate our goal of becoming the best-in-class solution for risk-based monitoring and clinical data analytics. We look forward to bringing additional competitive advantages to OmniComm's customers by delivering end-to-end RBM solutions and specialized data analytics expertise."

With two decades of operating experience, OmniComm will provide the Algorics team with an established and expanding marketplace. The acquisition will enable OmniComm to diversify and increase its product line. Additional benefits include:

  • Enhanced real-time and cross-study reporting capabilities for OmniComm's TrialMaster® and TrialOne® product lines.
  • AI/Machine-learning capabilities for remote monitoring of research sites.
  • End-to-end risk management framework in compliance with the recent ICH GCP E6 Addendum.
  • Expanded regional customer support in the Asia-Pacific market.
  • An office in India, which has become increasingly important for research and development initiatives in the pharmaceutical market.

"This acquisition fills a strong need for our customer base in the area of data aggregation and analytics, cross-study reporting and risk-based monitoring support," said Stephen Johnson, president and CEO of OmniComm. "The Acuity platform from Algorics perfectly complements and integrates with our TrialMaster EDC platform to improve clinical trials data quality, enhance our current risk-based monitoring capabilities and enable our clients to make better, real-time decisions throughout their clinical research."

OmniComm and Algorics both use the Microsoft Technology Stack, so the integration with TrialMaster and TrialOne is seamless, Mr. Johnson added.

No finder's fees are payable as a result of the proposed acquisition. Completion of the proposed acquisition is subject to a number of conditions including, but not limited to completion of satisfactory due diligence during a ninety (90) day due diligence period, the negotiation and execution of a definitive asset purchase agreement and approval of the Board of Directors of OmniComm. There can be no assurance that the transaction will be completed as proposed. The proposed acquisition is expected to close by the first quarter of 2018.

About Algorics
Algorics brings together a team of highly experienced software and life science professionals, united behind a single goal: to provide innovative risk-based monitoring and clinical analytics solutions and software to the global life sciences industry with consistent and reliable quality. Please visit www.algorics.com for more information.

About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world's pharmaceutical, biotechnology, contract research organizations (CROs), diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, these organizations drive efficiency in clinical development, better manage risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 5,000 clinical trials. Please visit www.omnicomm.com for more information.

Trademarks
OmniComm, TrialMaster, TrialOne and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.

Forward Looking Statements 
This document contains forward-looking statements that involve risks, uncertainties and assumptions. If any of these risks or uncertainties materializes or any of these assumptions proves incorrect, the results of OMCM and its consolidated subsidiaries could differ materially from those expressed or implied by such forward-looking statements.

All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of any financial items; any statements of the plans, strategies, and objectives of management for future operations, including the execution of integration and restructuring plans and the anticipated timing of closing relating to the planned acquisition; any statements concerning proposed new products, services, developments or industry rankings; any statements regarding future economic conditions or performance; any statements of belief and any statements of assumptions underlying any of the foregoing.

The risks, uncertainties and assumptions referred to above include the ability of OMCM to retain and motivate key employees; the timely development, production and acceptance of products and services and their feature sets; the difficulty of keeping expense growth at modest levels while increasing revenues; the challenges of integration and restructuring associated with the acquisition and the challenges of achieving anticipated synergies; the possibility that the planned acquisitions may not close and the other risks and uncertainties detailed in Part I, Item 1A. "Risk Factors," in the Company's Annual Report on Form 10-K for the year ended December 31, 2016 and in the Company's other filings made from time to time with the SEC (copies of which may be obtained through the Investor Relations portion of the Company's website under "SEC Filings").

The Company assumes no obligation to and does not intend to update these forward-looking statements.

Contact Info
Investor Relations
OmniComm Systems, Inc.
+1.954.473.1254
INVREL@omnicomm.com

Nithiya Ananthakrishnan
Algorics 
+91.997.279.9442
Nithiya@algorics.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: OmniComm Systems Inc. via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Fortuna reports 2017 production of 11.9 million silver equivalent ounces and issues guidance for 201817.1.2018 11:00Pressemelding

VANCOUVER, British Columbia, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Fortuna Silver Mines, Inc. (NYSE:FSM) (TSX:FVI) is pleased to announce 2017 production figures from its two underground operating silver mines, the San Jose Mine in Mexico and the Caylloma Mine in Peru. The company produced 8.5 million ounces of silver and 56.4 thousand ounces of gold or 11.9 million AgEq1 ounces. 2017 Consolidated Production Highlights Silver and gold production were 4 % and 8 % respectively above 2017 guidance Silver production of 8,469,593 ounces; 15 % increase over 2016 Gold production of 56,441 ounces; 21 % increase over 2016 Zinc production of 44,347,035 pounds; 3 % increase over 2016 Lead production of 29,877,890 pounds; 9 % decrease over 2016 Note: 1. Silver equivalent is calculated using silver to gold ratio of 60 to 1 2017 Consolidated Operating Results Q4 2017 2017 Caylloma, Peru San Jose, Mexico Consolidated Caylloma, Peru San Jose, Mexico Consolidated Processed Ore Tonnes milled 134,635 271,370

Standard Lithium Signs LOI for Development of Continuously-Operating Demonstration Pilot Plant17.1.2018 11:00Pressemelding

VANCOUVER, British Columbia, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSXV:SLL) (OTCQX:STLHF) (FRA:S5L) is pleased to announce that the Company has signed a non-binding Letter of Intent with a non-affiliated NYSE-listed company whereby, subject to the execution of a definitive agreement on terms acceptable to both parties (the "Definitive Agreement") and obtaining necessary consents and permits, the Company will design, build and operate a continuous demonstration scale pilot plant (the "Pilot Plant"), adjacent to certain existing chemical production facilities located in southern Arkansas. The Letter of Intent provides for a ninety-day period within which the Company and the other party will negotiate a Definitive Agreement in respect of the proposed Pilot Plant. Under the proposed Definitive Agreement, Standard Lithium would be permitted to build an in-place, continuously operating, pilot plant to explore and demonstrate a modern,

Seurat Technologies Closes $13.5 Million Series A Round Led by True Ventures17.1.2018 09:00Pressemelding

Funds Will Accelerate Commercialization of Breakthrough Metal Additive Manufacturing Technology BOSTON, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Seurat Technologies today announced it has closed a $13.5 million Series A round of funding led by True Ventures. Additional investors include GM Ventures, Porsche SE, next47 on behalf of Siemens Power and Gas, and Maniv Mobility. The funds will be used to accelerate the commercialization of Seurat's breakthrough metal additive manufacturing technology. Seurat previously raised $3.41 million in a seed financing led by True Ventures in June 2016. Seurat will bring to market an industrial metal printer with unparalleled speed and resolution. "We've been able to hit some significant milestones over the past few months," said Erik Toomre, CEO of Seurat Technologies. "These funds will give us the fuel we need to rapidly accelerate our ability to commercialize this breakthrough with an initial focus on the automotive, energy, and aerospace sectors." "Metal

Doc re. GE Files 8-K17.1.2018 08:00Pressemelding

FAIRFIELD, Conn., Jan. 17, 2018 (GLOBE NEWSWIRE) -- On January 16, 2018, General Electric Company (the "Company") filed a Form 8-K with the U.S. Securities and Exchange Commission ("SEC"), which has been submitted to the U.K. National Storage Mechanism and will be available shortly for inspection at http://www.morningstar.co.uk/uk/NSM. It is also available on the SEC's website at http://www.sec.gov and on the Company's website at https://www.ge.com/investor-relations/events-reports. CONTACT: GE Jennifer Erickson +001 646 682 5620 jennifer.erickson@ge.com This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: General Electric Company via Globenewswire

Ascom wins agreement with IDN Munson Healthcare in the USA16.1.2018 17:30Pressemelding

Ascom Holding AG / Ascom wins agreement with IDN Munson Healthcare in the USA . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Ascom secures an agreement with the Integrated Delivery Network (IDN) Munson Healthcare to upgrade its flagship medical center. The agreement amounts to CHF 1.1 million and includes the full Ascom Healthcare Platform. BAAR, Switzerland, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Munson Healthcare, a nine hospital non-profit Integrated Delivery Network (IDN) serving the state of Michigan, selected Ascom (SWX:ASCN.SW), the leading global healthcare Information and Communication Technology (ICT) provider, for a comprehensive technology retrofit of its flagship Munson Medical Center. The CHF 1.1 million agreement signed in the second half of 2017 is notable for encompassing the full Ascom Healthcare Platform, including Telligence nurse call, Unite software, EMR and RTLS integrations, Ascom mobi

Enter Introduces SD-WAN Service on Its National and International Ethernet Infrastructure16.1.2018 16:40Pressemelding

MILAN, Italy, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Enter, a leader in network and cloud services based in Italy, today announces the market introduction of its Software-Defined Wide Area Network (SD-WAN) service on its national and international Ethernet infrastructure. The solution is purpose-built to serve both enterprise and carrier customers. Enterprise customers will be able to take advantage of Enter's hybrid Wide Area Network (WAN), distributed across 35+ national and international Points of Presence (PoPs) to ensure global coverage and SD-WAN service availability. This will streamline network control for branch locations, simplifying enterprise WAN management for both cloud-based and on-premises applications. The service allows users to prioritize select business-critical applications and monitor application performance through an easy-to-use analytics portal. Enter's new SD-WAN offering enables carrier customers to facilitate and increase interconnections by opening the door to m

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom